| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 09/22/2005 | US20050209273 Neuroprotectants, analgesics or anticonvulsants |
| 09/22/2005 | US20050209216 Inhibit the synthesis of TNF-alpha (TNF=tumor necrosis factor); use treating diseases linked to immune and inflammatory disorders or as analgesics; e.g. 7-(2-(4-(3-Trifluoromethylphenyl)piperazin-1-yl)ethyl)quinoline |
| 09/22/2005 | US20050209213 Quinoline compound |
| 09/22/2005 | US20050204619 Preparing rutin-containing extract which has pure rutin in high content using water culture system by germinating buckwheat seed, growing seed into mature buckwheat which contains greatest amount of rutin, and extracting rutin-containing extract from mature buckwheat; treatment of vascular diseases |
| 09/22/2005 | CA2560111A1 Aminophenylpropanoic acid derivative |
| 09/22/2005 | CA2555867A1 Arylalkylamino-substituted quinazoline analogues |
| 09/21/2005 | EP1575925A1 Novel carboxamides, the production and use thereof as medicaments |
| 09/21/2005 | EP1575923A2 CARDIOTONIC COMPOUNDS WITH INHIBITORY ACTIVITY AGAINST &bgr;-ADRENERGIC RECEPTORS AND PHOSPHODIESTERASE |
| 09/21/2005 | EP1575903A1 Compounds for the inhibition of rotamases |
| 09/21/2005 | EP1575589A1 Atropisomers of 3-substituted-4-arylquinolin-2-one derivatives |
| 09/21/2005 | CN1671667A Quinoline derivatives and their use as mycobacterial inhibitors |
| 09/21/2005 | CN1670026A Lotus plumule alkaloid extract and its preparation process and use in preparation of drugs for cardiovascular and cerebrovascular diseases |
| 09/21/2005 | CN1219780C Heterocyclic compounds binding chemotactic factor receptor |
| 09/21/2005 | CN1219769C New process for preparing quinolone-carboxylic acid |
| 09/21/2005 | CN1219768C Quinoline derivatives as inhibitors of MEK enzymes |
| 09/20/2005 | US6946688 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
| 09/20/2005 | US6946568 Titanium, zirconium, hafnium, vandium, niobium or tantalum complexed with an imine and an amine, oxy or sulfide |
| 09/20/2005 | US6946557 Cellulose tris (4-chlorophenyl carbamate) on stationary phase in liquid chhromatograhy column separates optical isomers |
| 09/20/2005 | US6946474 Nitrogen-containing compounds and their use as glycine transport inhibitors |
| 09/20/2005 | CA2119757C New fluoro quinoline carboxylic-3 acid derivatives and their preparation |
| 09/15/2005 | WO2005085181A1 Functional material comprising fluorine compound |
| 09/15/2005 | WO2005051300A3 Bicyclic inhibitors of mek and methods of use thereof |
| 09/15/2005 | WO2005049589A3 Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases |
| 09/15/2005 | WO2005012579A3 Homodimeric cyanine dye dimer comprising aromatic, heteroaromatic, cyclic or heterocyclic linker moiety in nucleic acid reporter molecules |
| 09/15/2005 | WO2004080971A8 Tetrahydroquinoline derivatives useful as serine protease inhibitors |
| 09/15/2005 | US20050203317 Removing the allyl group in a single reaction step with a high reaction rate and a high functional group selectivity without using any additive; cyclopentadienyl ruthenium (II) complex; catalytic dehydration type reaction of alcohols using the ruthenium complex |
| 09/15/2005 | US20050203301 Processes for producing 7-isoindoline-quinolone carboxylic acid derivative and its intermediate, as well as salt of 7-isoindoline-quinolonecarboxylic acid derivative, its hydrate and composition comprising the same as active ingredient |
| 09/15/2005 | US20050203299 Slurrying aripiprazole in a solvent (acetone), heating and isolating anhydrous aripiprazole Form II from the slurry |
| 09/15/2005 | US20050203129 1, 2-Dihydroquinoline derivatives and method for using the same to treat HIV infections |
| 09/15/2005 | US20050203128 Antiinflammatory agents; antiallergens; antiproliferative agents; 4-(5-Fluoro-2-hydroxy-phenyl)-2-hydroxy-4-methyl-2-trifluoromethyl-pentanoic acid (3,5-dichloro-phenyl)-amide |
| 09/15/2005 | US20050203119 Dihydropyridine compounds for treating or preventing metabolic disorders |
| 09/15/2005 | US20050203108 Glucagon antagonists/inverse agonists |
| 09/15/2005 | US20050203096 Compounds to treat Alzheimer's disease |
| 09/15/2005 | US20050198773 Magnetism to control compressive friction checks for rods including those of door closers |
| 09/15/2005 | DE102004004972B3 Heterocyclisch substituierte 7-Amino-4-chinolon-3-carbonsäure-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Heterocyclic-substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, to processes for their preparation and their use as medicaments |
| 09/14/2005 | EP1574501A1 Quinolinone derivatives, pharmaceutical compositions containing them and their use |
| 09/14/2005 | EP1574500A1 Quinoline derivative as diagnostic probe for disease with tau protein accumulation |
| 09/14/2005 | EP1572657A1 Processes for preparing quinolonecarboxylate derivatives |
| 09/14/2005 | EP1572239A1 Method of using a cox-2 inhibitor and a topoisomerase ii inhibitor as a combination therapy in the treatment of neoplasia |
| 09/14/2005 | CN1668599A Process for preparing quinolone antibiotic intermediates |
| 09/14/2005 | CN1668597A Process for producing 2, 3, 6-trialkyl-8-fluoro-4-quinoline derivative |
| 09/13/2005 | US6943196 NF-κB inhibitor comprising phenylmethyl benzoquinone as the active ingredient |
| 09/13/2005 | US6943170 N-cycloalkylglycines as HIV protease inhibitors |
| 09/13/2005 | US6943169 Quinolinone derivatives and uses thereof |
| 09/13/2005 | CA2231105C Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives |
| 09/10/2005 | CA2500136A1 Method of removing allyl series protecting group using novel ruthenium complex and method of synthesizing allyl ethers |
| 09/09/2005 | WO2005082882A1 Hydrazide type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases |
| 09/09/2005 | WO2005082857A1 Substituted quinoline compounds for use as selective estrogen receptor modulator |
| 09/09/2005 | WO2005082856A2 Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors |
| 09/09/2005 | WO2005082841A1 Immunosuppressant compounds and compositions |
| 09/09/2005 | WO2005082820A1 Method for preparation of a fluoroaromatic compound from an aminoaromatic amine compound. |
| 09/09/2005 | CA2554439A1 Hydrazide type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases |
| 09/09/2005 | CA2553572A1 Immunosuppressant compounds and compositions |
| 09/08/2005 | US20050197501 Reacting calcium hydroxide with an ester derivative or protected ester derivative of the statin; rosuvastatin, pitavastatin and atorvastatin, simvastatin and lovastatin |
| 09/08/2005 | US20050197371 Urea derivatives as PDGFR modulators |
| 09/08/2005 | US20050197362 Preventives/remedies for urinary disturbance |
| 09/08/2005 | US20050197361 Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors |
| 09/08/2005 | US20050197350 Melanin Concentrating Hormone (MCH) receptor antagonist; clinical obesity; eating disorders; N-(cis-4-{[4-(dimethylamino)quinolin-2-yl]amino}cyclohexyl)-3-methoxy-benzamide; N-(2-chlorobenzyl)-N'-(cis-4-{[4- -(dimethylamino)-5,6,7,8-tetrahydroquinazolin-2-yl]amino}cyclohexyl)urea; pyrimidine analogs |
| 09/08/2005 | US20050197331 Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production |
| 09/07/2005 | EP1571142A1 Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production |
| 09/07/2005 | EP1569932A1 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2 |
| 09/07/2005 | EP1569916A1 Substituted aralkyl derivatives |
| 09/07/2005 | EP1569637A1 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 09/07/2005 | EP1366039B1 Piperazinylcarbonylquinolines and -isoquinolines |
| 09/07/2005 | EP1192132B1 Serine protease inhibitors |
| 09/07/2005 | EP1042295B1 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents |
| 09/07/2005 | CN1665806A Medicine compound |
| 09/07/2005 | CN1665792A Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses |
| 09/07/2005 | CN1665787A Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles |
| 09/07/2005 | CN1665537A Use of CETP inhibitors and optionally HMG COA reductable inhibitors and/or antihypertensive agents |
| 09/07/2005 | CN1665504A Novel crystalline forms of gatifloxacin |
| 09/07/2005 | CN1665502A MCHIR antagonists |
| 09/07/2005 | CN1663952A Preparation of quinoline-substituted carbonate and carbamate derivatives |
| 09/07/2005 | CN1217936C Heterocyclic compounds having sulfonamide |
| 09/07/2005 | CN1217935C Organic electroluminescent material and its preparation method and application |
| 09/07/2005 | CN1217934C Prepn. of quinoline-substituted carbonate and carbamate derivatives |
| 09/07/2005 | CN1217920C Compounds to treat Alzheimer disease |
| 09/06/2005 | US6939968 Atropisomers of 3-substituted-4-arylquinolin-2-one derivatives |
| 09/06/2005 | US6939895 Renalosteodystrophy comprising a compound, or a pharmaceutically acceptable salt or hydrate thereof, having the formula: Ar5-(CHR16)t-W-(CH2)u-CHR17)-NH-CH(R18)-Ar6 wherein: Ar5 is phenyl, indole, carbazole, pyridine, |
| 09/06/2005 | CA2067690C Amino acid derivatives |
| 09/01/2005 | WO2005080377A1 COMPOUND HAVING TGF-β INHIBITORY ACTIVITY AND PHARMACEUTICAL COMPOSITION CONTAINING SAME |
| 09/01/2005 | WO2005080373A1 Substituted quinoline compounds |
| 09/01/2005 | WO2005080371A1 Amino heterocyclic modulators of chemokine receptor activity |
| 09/01/2005 | WO2005080361A1 Histamine-3 receptor modulators |
| 09/01/2005 | WO2005080317A2 Therapeutic amide derivatives |
| 09/01/2005 | WO2003101941A3 Alpha acyloxyacetamides for kallikrein and urokinase inhibition |
| 09/01/2005 | US20050192316 Aryl aniline beta2 adrenergic receptor agonists |
| 09/01/2005 | US20050192314 Use of urea derivatives of isoxazoles; c-kit kinase inhibitors; anticancer agents; leukemias such as acute myelogenous leukemia (AML), and chronic myelogenous leukemias (CMLs) |
| 09/01/2005 | US20050192283 Fused-aryl and heteroaryl derivatives and methods of their use |
| 09/01/2005 | DE102004004973A1 New 7-phenylamino-quinolone or 1,8-naphthyridone derivatives, useful e.g. for treating type II diabetes or arteriosclerosis, are inhibitors of glycogen phosphorylase |
| 09/01/2005 | CA2555970A1 Therapeutic amide derivatives |
| 09/01/2005 | CA2555133A1 Substituted quinoline compounds |
| 09/01/2005 | CA2555073A1 Amino heterocyclic modulators of chemokine receptor activity |
| 09/01/2005 | CA2555071A1 Histamine-3 receptor modulators |
| 09/01/2005 | CA2498644A1 Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (no) production |
| 08/31/2005 | EP1568694A1 N-heteroaryl-para-phenylene diamines for colouring hair |
| 08/31/2005 | EP1568693A1 Process for producing quinolinecarbaldehyde |
| 08/31/2005 | EP1568692A1 (pyridin-4-yl)alkyl-amides as TNF-alpha production inhibitors |
| 08/31/2005 | EP1568690A1 The use of carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones as sodium channel blockers |
| 08/31/2005 | EP1567511A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |